Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection

In Vivo

Volumn 29, Issue 3, 2015, Pages 399-404

  Gentile, Ivan ^a   Scarano, Filomena ^a   Celotti, Anna ^a   De Iuliis, Enrica ^b   Scarano, Rosanna ^b   Granata, Vincenza ^b   Pinchera, Biagio ^a   Meola, Mariangela ^a   D'Ambra, Antonietta ^a   Piccirillo, Mauro ^b   Di Paola, Flaviano ^b   Cavalcanti, Ernesta ^b   Izzo, Francesco ^b   Scarpato, Nicola ^a   Borgia, Guglielmo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Extrahepatic manifestation; Hepatitis C; Immune regulation; Low antigen diet; Lymphoma; Metabolism

Indexed keywords

CRYOGLOBULIN; PEGINTERFERON; RIBAVIRIN; VITAMIN D; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS C; CRYOGLOBULINEMIA; DISEASE SEVERITY; FEMALE; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; BLOOD; METABOLISM; MIDDLE AGED; VIROLOGY;

AGED; BIOMARKERS; CRYOGLOBULINS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84933040091     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. WHO. Hepatitis C. 2014 [02 July 2014]; Available from: http://www.who.int/mediacentre/factsheets/fs164/en/.
2. Petruzziello A, Coppola N, Diodato AM, Iervolino V, Azzaro R, Di Costanzo G, Di Macchia CA, Di Meo T, Loquercio G, Pasquale G and Cacciapuoti C: Age and gender distribution of hepatitis C virus genotypes in the metropolitan area of Naples. Intervirology 56: 206-212, 2013.
3. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA and Zignego AL: HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 39: S13-21, 2007.
4. Ferri C, Zignego AL and Pileri SA: Cryoglobulins. J Clin Pathol 55: 4-13, 2002.
5. Zignego AL, Ferri C, Pileri SA, Caini P and Bianchi FB: Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39: 2-17, 2007.
6. Fusco F, D'Anzeo G, Rossi A, Sciorio C, Buonomo AR, d'Emmanuele di Villa Bianca R, Borgia G, Mirone V and Gentile I: Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature. Expert Opin Pharmacother 14: 2533-2544, 2013.
7. Gentile I, Viola C, Graf M, Liuzzi R, Quarto M, Cerini R, Piazza M and Borgia G: A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. J Clin Gastroenterol 43: 81-87, 2009.
8. Davis GL, Alter MJ, El-Serag H, Poynard T and Jennings LW: Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138: 513-521, 2010.
9. Maasoumy B and Wedemeyer H: Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol 26: 401-412, 2012.
10. Gentile I, Buonomo AR, Zappulo E and Borgia G: Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters? Infez Med 22: 11-18, 2014.
11. Coppola N, Gentile I, Pasquale G, Buonomo AR, Capoluongo N, D'Armiento M, Borgia G and Sagnelli E: Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. Ann Hepatol 13: 20-26, 2013.
12. Gentile I, Coppola N, Pasquale G, Liuzzi R, D'Armiento M, Di Lorenzo ME, Capoluongo N, Buonomo AR, Sagnelli E, Morisco F, Caporaso N and Borgia G: A simple noninvasive score based on routine parameters can predict liver cirrhosis in patients with chronic Hepatitis C. Hepatitis Monthly 13: e8352, 2013.
13. Fortunato G, Calcagno G, Bresciamorra V, Salvatore E, Filla A, Capone S, Liguori R, Borelli S, Gentile I, Borrelli F, Borgia G and Sacchetti L: Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes. J Interferon Cytokine Res 28: 141-152, 2008.
14. Fortunato G, Castaldo G, Oriani G, Cerini R, Intrieri M, Molinaro E, Gentile I, Borgia G, Piazza M, Salvatore F and Sacchetti L: Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin Chem 47: 1696-1700, 2001.
15. Gentile I, Meola M, Buonomo AR, Minei G, Coppola N, Foggia M, Ferruzzi F, Fratellanza G, Scarpato N and Borgia G: Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection. In Vivo 27: 773-777, 2013.
16. Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S, Orlando E and Petta S: Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int 564645: 17, 2013.
17. Missiha SB, Ostrowski M and Heathcote EJ: Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology 134: 1699-1714, 2008.
18. Sagnelli E, Coppola N, Marrocco C, Onofrio M, Sagnelli C, Coviello G, Scolastico C and Filippini P: Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course. J Clin Virol 35: 317-320, 2006.
19. Sagnelli E, Pisaturo M, Stanzione M, Messina V, Alessio L, Sagnelli C, Starace M, Pasquale G and Coppola N: Presentation, Outcomes, and response to therapy among patients with acute exacerbation of chronic hepatitis C. Clin Gastroenterol Hepatol 13: 00466-00467, 2013.
20. Coppola N, Zampino R, Sagnelli C, Bellini G, Marrone A, Stanzione M, Capoluongo N, Boemio A, Minichini C, Adinolfi LE, Maione S, Giudice EM, Sagnelli E and Rossi F: Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C. PLoS One 9, 2014.
21. Petruzziello A, Coppola N, Loquercio G, Marigliano S, Giordano M, Azzaro R, Diodato AM, Iervolino V, Di Costanzo G, Di Macchia CA, Di Meo T, Paradiso L, Ferro R, Giuliano P, Russo F, Pasquale G and Cacciapuoti C: Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients. Intervirology 57: 311-318, 2014.
22. Sagnelli C, Uberti-Foppa C, Pasquale G, De Pascalis S, Coppola N, Albarello L, Doglioni C, Lazzarin A and Sagnelli E: Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection. Infection 41: 959-967, 2013.
23. Gentile I, Viola C, Paesano L, D'Onofrio M, D'Agostino E, Cerini R, Borrelli F, Piazza M and Borgia G: Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial. J Clin Apher 24: 190-196, 2009.
24. Zampino R, Pisaturo MA, Cirillo G, Marrone A, Macera M, Rinaldi L, Stanzione M, Durante-Mangoni E, Gentile I, Sagnelli E, Signoriello G, Miraglia Del Giudice E, Adinolfi LE and Coppola N: Hepatocellular carcinoma in chronic HBV-HCV coinfection is correlated to fibrosis and disease duration. Ann Hepatol 14: 75-82, 2015.
25. Paroli M, Iannucci G and Accapezzato D: Hepatitis C virus infection and autoimmune diseases. Int J Gen Med 5: 903-907, 2012.
26. Bianchi FB, Muratori P, Granito A, Pappas G, Ferri S and Muratori L: Hepatitis C and autoreactivity. Dig Liver Dis 39: S22-24, 2007.
27. Della Rossa A, Marchi F, Catarsi E, Tavoni A and Bombardieri S: Mixed cryoglobulinemia and mortality: a review of the literature. Clin Exp Rheumatol 26: S105-108, 2008.
28. Takada S, Shimizu T, Hadano Y, Matsumoto K, Kataoka Y, Arima Y, Inoue T and Sorano S: Cryoglobulinemia (review). Mol Med Rep 6: 3-8, 2012.
29. Charles ED and Dustin LB: Hepatitis C virus-induced cryoglobulinemia. Kidney Int 76: 818-824, 2009.
30. Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, el-Gohary A, Orii K, Ijima A, Rokuhara A, Yoshizawa K, Nooman Z and Kiyosawa K: Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence. J Med Virol 70: 594-599, 2003.
31. Cacoub P, Renou C, Kerr G, Hue S, Rosenthal E, Cohen P, Kaplanski G, Charlotte F, Thibault V, Ghillani P, Piette JC and Caillat-Zucman S: Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44: 2118-2124, 2001.
32. Sebastiani GD, Bellisai F, Caudai C, Rottoli P, Valensin PE, Pippi L, Morozzi G, Porciello G, Donvito A, Bilenchi R, Giannini F and Galeazzi M: Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients. J Biol Regul Homeost Agents 19: 17-22, 2005.
33. Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G and Galli M: Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 10: 444-454, 2011.
34. Gentile I, Borgia F, Buonomo AR, Castaldo G and Borgia G: A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir. Curr Med Chem 20: 3733-3742, 2013.
35. Gentile I, Coppola N, Buonomo AR, Zappulo E and Borgia G: Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus. Expert Opin Investig Drugs 21: 1-13, 2014.
36. Gentile I, Buonomo AR, Zappulo E and Borgia G: Interferon-free therapies for chronic hepatitis C: Toward a hepatitis C virus-free world? Expert Rev Anti Infect Ther 12: 763-773, 2014.
37. Gentile I, Buonomo AR and Borgia G: Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection. Rev Recent Clin Trials 29: 29, 2014.
38. Gentile I, Borgia F, Coppola N, Buonomo AR, Castaldo G and Borgia G: Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A. Curr Med Chem 21: 1391-1404, 2014.
39. Gentile I, Buonomo A, Zappulo E, Minei G, Morisco F, Borrelli F, Coppola N and Borgia G: Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. Therapeutics and Clinical Risk Management 10: 493-504, 2014.
40. Gentile I, Buonomo AR, Zappulo E, Coppola N and Borgia G: GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection. Expert Rev Anti Infect Ther 12: 1179-1186, 2014.
41. Gentile I, Buonomo AR, Zappulo E and Borgia G: Discontinued drugs in 2012-2013: hepatitis C virus infection. Expert Opin Investig Drugs 24: 239-251, 2015.
42. Gentile I, Buonomo AR and Borgia G: Ombitasvir: a potent pangenotypic inhibitor of NS5A for the treatment of hepatitis C virus infection. Expert Rev Anti Infect Ther 12: 1033-1043, 2014.
43. Gentile I, Buonomo AR, Borgia F, Castaldo G and Borgia G: Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. Expert Opin Investig Drugs 23: 561-571, 2014.
44. Gentile I and Borgia G: Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment. Evid Based Med 19: 223-224, 2014.
45. Gentile I, Borgia F, Buonomo AR, Zappulo E, Castaldo G and Borgia G: ABT-450: a novel protease inhibitor for the treatment of hepatitis C virus infection. Curr Med Chem 21: 3261-3270, 2014.
46. Gentile I, Buonomo AR, Borgia F, Zappulo E, Castaldo G and Borgia G: MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection. Expert Opin Investig Drugs 23: 719-728, 2014.
47. Gentile I, Borgia F, Zappulo E, Buonomo AR, Spera AM, Castaldo G and Borgia G: Efficacy and safety of sofosbuvir in treatment of chronic hepatitis C: The dawn of the a new era. Rev Recent Clin Trials 13: 13, 2013.
48. Cannell JJ and Hollis BW: Use of vitamin D in clinical practice. Altern Med Rev 13: 6-20, 2008.
49. Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sene D, Poynard T, Souberbielle JC and Cacoub P: Low serum 25-hydroxyvitamin D levels correlate with the presence of extrahepatic manifestations in chronic hepatitis C virus infection. Rheumatology 51: 2083-2090, 2012.
50. Arteh J, Narra S and Nair S: Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 55: 2624-2628, 2010.
51. Gentile I, Zappulo E, Militerni R, Pascotto A, Borgia G and Bravaccio C: Etiopathogenesis of autism spectrum disorders: fitting the pieces of the puzzle together. Med Hypotheses 81: 26-35, 2013.